Page last updated: 2024-10-22

amfenac and Cancer of the Retina

amfenac has been researched along with Cancer of the Retina in 1 studies

amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.

Research Excerpts

ExcerptRelevanceReference
"When amfenac was added to both of the cell lines, a statistically significant reduction in proliferation was observed in both cell lines."1.33The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines. ( Anteka, E; Burnier, MN; Correa, ZM; Coutinho, AB; de Souza Filho, JP; Marshall, JC; Martins, MC, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Souza Filho, JP1
Correa, ZM1
Marshall, JC1
Anteka, E1
Coutinho, AB1
Martins, MC1
Burnier, MN1

Other Studies

1 other study available for amfenac and Cancer of the Retina

ArticleYear
The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines.
    Eye (London, England), 2006, Volume: 20, Issue:5

    Topics: Blotting, Western; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Phenyl

2006